Astrana Health Inc (ASTH)

Currency in USD
35.76
+1.63(+4.78%)
Closed·
34.00-1.76(-4.92%)
·
ASTH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
34.4836.60
52 wk Range
18.0851.60
Key Statistics
Prev. Close
34.13
Open
34.54
Day's Range
34.48-36.6
52 wk Range
18.08-51.6
Volume
909.93K
Average Volume (3m)
609.93K
1-Year Change
27.3504%
Book Value / Share
18.44
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ASTH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
50.50
Upside
+41.22%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Astrana Health Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

9 Buy
1 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 50.50
(+41.22% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Barclays
Buy53.00+48.21%50.00MaintainAug 07, 2026
Barclays
Buy50.00+39.82%37.00UpgradeMay 26, 2026
Truist Securities
Buy47.00+31.43%38.00MaintainMay 14, 2026
TD Cowen
Buy45.00+25.84%35.00MaintainMay 12, 2026
Barclays
Hold37.00+3.47%26.00MaintainMay 11, 2026

Astrana Health Inc Earnings Call Summary for Q2/2026

  • Astrana Health Q2 adjusted EPS of $0.80 beat estimates by 142%, though revenue of $972.5M missed forecasts by 1.34%; shares rose 4.34% after hours.
  • Adjusted EBITDA increased 43% YoY to $69M; full-year guidance raised to $255M-$280M, reflecting strong operational leverage and Prospect synergies.
  • Company reduced debt by $92M in Q2, improving leverage to 3.8x from 4.2x; first-half free cash flow reached $93M with 69% conversion rate.
  • Q3 revenue guidance set at $1.0B-$1.03B with adjusted EBITDA of $72.5M-$77.5M; management reaffirmed mid-to-high teens EBITDA growth for 2027.
  • CEO emphasized AI-driven competitive advantage and strategic reinvestment in new markets; risks include Medicaid attrition and upcoming work requirements.
Last Updated: 07/08/2026, 00:06
Read Full Transcript

Earnings

Latest Release
Aug 06, 2026
EPS / Forecast
0.80 / 0.33
Revenue / Forecast
972.5M / 985.72M
EPS Revisions
Last 90 days

ASTH Income Statement

Compare ASTH to Peers and Sector

Metrics to compare
ASTH
Peers
Sector
Relationship
P/E Ratio
43.4x23.0x−0.4x
PEG Ratio
0.730.600.00
Price/Book
2.1x3.3x2.6x
Price / LTM Sales
0.5x1.4x3.0x
Upside (Analyst Target)
40.0%16.0%48.7%
Fair Value Upside
Unlock8.9%5.6%Unlock

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
17.48M38.82%624.99M
Other Institutional Investors
19.89M44.19%711.38M
Public Companies & Retail Investors
7.65M16.99%273.56M
Total
45.02M100.00%1.61B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Allied Physicians of California IPA15.18%6,832,698244,337
BlackRock, Inc.13.69%6,163,727220,415

People Also Watch

138.00
Q
+3.47%
74.98
MXL
+6.81%
256.12
SIMO
-4.23%
412.39
CIEN
+2.14%

FAQ

What Is the Astrana Health (ASTH) Stock Price Today?

The Astrana Health stock price today is 35.76 USD.

What Stock Exchange Does Astrana Health Trade On?

Astrana Health is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Astrana Health?

The stock symbol for Astrana Health is "ASTH."

What Is the Astrana Health (ASTH) Afterhours Price Today? (Afterhours variable test: 34.00) Current Date: Aug 08, 2026

After hours price: 34.00. After hours price change (units): -1.76. Price change percentage: -4.92%

What Is the Astrana Health Market Cap?

As of today, Astrana Health market cap is 1.68B USD.

What Is Astrana Health's Earnings Per Share (TTM)?

The Astrana Health EPS (TTM) is 0.83.

When Is the Next Astrana Health Earnings Date?

Astrana Health will release its next earnings report on Nov 05, 2026.

From a Technical Analysis Perspective, Is ASTH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Astrana Health Stock Split?

Astrana Health has split 1 times.

How Many Employees Does Astrana Health Have?

Astrana Health has 3000 employees.

What is the current trading status of Astrana Health (ASTH)?

As of Aug 08, 2026, Astrana Health (ASTH) is trading at a price of 35.76 USD, with a previous close of 34.13 USD. The stock has fluctuated within a day range of 34.48 USD to 36.60 USD, while its 52-week range spans from 18.08 USD to 51.60 USD.

What Is Astrana Health (ASTH) Price Target According to Analysts?

The average 12-month price target for Astrana Health is 50.50 USD, with a high estimate of 65 USD and a low estimate of 41 USD. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +41.22% Upside potential.

What Is the ASTH Premarket Price?

ASTH's last pre-market stock price is 35.15 USD. The pre-market share volume is 1,040.00, and the stock has decreased by 1.02, or 2.99%.

What Is the ASTH After Hours Price?

ASTH's last after hours stock price is 34.00 USD, the stock has decreased by -1.76, or -4.92%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.